Medical Cannabis for TBI in Personal Injury: Legal and Pharmaceutical Considerations

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 7 min read

Medical cannabis is increasingly used for traumatic brain injury symptoms in PI cases. Attorneys should understand the legal, evidentiary, and pharmaceutical implications. LienScripts pharmacy lien services cover FDA-approved medications while attorneys navigate cannabis-related case issues.

Medical cannabis is being prescribed with increasing frequency for traumatic brain injury (TBI) symptoms including chronic headache, insomnia, anxiety, PTSD, and seizure management in states that have authorized medical cannabis programs. For personal injury attorneys, medical cannabis use by TBI plaintiffs creates both opportunities and challenges: it demonstrates the severity of the plaintiff's condition and treatment-seeking behavior, but it also creates potential evidentiary issues that defense counsel may exploit. Pharmacy lien services through LienScripts cover all FDA-approved medications for TBI management, while attorneys navigate the separate legal and evidentiary considerations surrounding medical cannabis use.

• Medical cannabis is authorized in most states for conditions common in TBI cases including chronic pain, PTSD, seizures, and insomnia
• Medical cannabis use by PI plaintiffs creates evidentiary considerations that attorneys must manage
• LienScripts pharmacy liens cover all FDA-approved TBI medications including pain management, anti-seizure, sleep, and psychiatric drugs
• The MERIT report documents FDA-approved medication management alongside any medical cannabis documentation
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

Medical Cannabis and TBI: The Clinical Context

Research into cannabinoid therapy for TBI is evolving. Several clinical areas show promise:

Post-traumatic headache. Some TBI patients report improvement in chronic headache frequency and severity with medical cannabis, particularly when conventional medications have been insufficient.

Sleep disruption. TBI commonly disrupts sleep architecture. Certain cannabis formulations are used to address insomnia when standard sleep medications are ineffective or cause unacceptable side effects.

PTSD symptoms. Post-traumatic stress disorder frequently accompanies TBI. Medical cannabis programs in many states list PTSD as a qualifying condition.

Seizure management. Some TBI patients develop post-traumatic epilepsy. Cannabidiol (CBD), specifically the FDA-approved product Epidiolex, has demonstrated anticonvulsant properties.

According to James Wong, PharmD, founder of LienScripts, "Medical cannabis for TBI is a legitimate clinical consideration in states where it is authorized. The pharmacy lien covers the full spectrum of FDA-approved medications for TBI symptoms. Attorneys need to understand how medical cannabis use interacts with the pharmaceutical evidence in their cases."

Evidentiary Considerations for Attorneys

Defense Arguments About Cannabis Use

Defense counsel may attempt to use a plaintiff's medical cannabis use in several ways:

Pre-existing substance use. Defense may argue that cannabis use predates the injury and is not injury-related, even when medical authorization was obtained specifically for TBI symptoms.

Credibility attacks. In jurisdictions where cannabis remains stigmatized, defense may attempt to use medical cannabis to undermine the plaintiff's credibility with jurors.

Alternative causation. Defense may argue that cognitive symptoms the plaintiff attributes to TBI are actually caused by cannabis use.

Medication interaction claims. Defense may suggest that cannabis interacts with prescribed medications in ways that complicate the treatment narrative.

Proactive Attorney Strategies

Document the timeline. If medical cannabis authorization occurred after the TBI, establish the temporal relationship clearly. The medical cannabis evaluation records should show that the authorization was specifically for injury-related symptoms.

Integrate with treatment narrative. Position medical cannabis use as part of the comprehensive treatment approach, alongside FDA-approved medications documented in the MERIT report. The plaintiff sought treatment through every available avenue, which demonstrates injury severity.

Understand state law. State laws vary significantly on the admissibility of medical cannabis records and the use of lawful medical cannabis against a party in litigation. Know the applicable protections before trial.

FDA-Approved Medications for TBI Symptoms

The pharmacy lien through LienScripts covers all FDA-approved medications prescribed for TBI-related conditions:

Headache Management

Anti-migraine medications, preventive headache treatments, and analgesics for post-traumatic headache are covered under the lien. These medications form the primary pharmacological approach to TBI headache management.

Seizure Prevention

Anti-seizure medications including levetiracetam, lamotrigine, and FDA-approved cannabidiol (Epidiolex) are covered when prescribed for post-traumatic epilepsy.

Sleep Management

Sleep medications including trazodone, zolpidem, and melatonin receptor agonists are covered for TBI-related insomnia. These medications are documented in the comprehensive sleep medication guide for PI cases.

Psychiatric Medications

Antidepressants, anti-anxiety medications, and PTSD-specific treatments are covered for the psychiatric consequences of TBI.

Cognitive Support

Medications that support cognitive function and attention after TBI are covered when prescribed by the treating physician.

Documentation Strategy

Parallel Documentation

The MERIT report from LienScripts documents all FDA-approved medications dispensed under the lien. Medical cannabis documentation exists separately through the state medical cannabis program. Attorneys should maintain parallel records that show the comprehensive treatment approach.

Treatment Hierarchy

Position the medication timeline to show that conventional FDA-approved treatments were initiated first, and that medical cannabis was added when those treatments were insufficient for symptom control. This treatment hierarchy narrative is persuasive to adjusters and juries.

Clinical Rationale

Obtain documentation from the treating physician explaining why medical cannabis was recommended. The physician's clinical rationale, particularly when connected to specific TBI symptoms that were not adequately controlled by conventional medications, supports the medical necessity argument.

Practical Guidance

Attorneys handling TBI cases where the plaintiff uses medical cannabis should enroll the client in the LienScripts pharmacy lien for all FDA-approved medications and maintain separate documentation for medical cannabis treatment. The combination demonstrates comprehensive treatment-seeking behavior and documents the full scope of the plaintiff's pharmaceutical needs. Understanding both the FDA-approved medication landscape and the medical cannabis considerations enables attorneys to build the strongest possible case narrative.